Resazurin

Resazurin

SCHEMBL272629

O=c1ccc2[n+]([O-])c3ccc(O)cc3oc-2c1.[Na+]

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Resazurin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 1/20 0.72
ESR2 known ✓ Q92731 2/20 0.38
CA12 known ✓ O43570 2/20 0.35
CA1 known ✓ P00915 2/20 0.35
CA2 known ✓ P00918 2/20 0.35
XDH known ✓ P47989 1/20 0.35
PTGS1 known ✓ P23219 1/20 0.35
KMT2A Q03164 7/20 0.72
MEN1 O00255 6/20 0.72
POLB P06746 4/20 0.72
KDM4E B2RXH2 4/20 0.72
MAPK1 P28482 2/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
CASP6 P55212 2/20 0.72
GAA P10253 2/20 0.72
MCL1 Q07820 2/20 0.72
TDP1 Q9NUW8 2/20 0.72
PKM P14618 2/20 0.72
MAPT P10636 2/20 0.72
APEX1 P27695 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resazurin SCHEMBL29370889 0.99 KMT2A (0.70) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL6338 0.99 KMT2A (0.70) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL8665938 0.99 KMT2A (0.70) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL10937342 0.97 KMT2A (0.68) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL21823760 0.97 KMT2A (0.68) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL29456662 0.97 KMT2A (0.68) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL5492813 0.97 KMT2A (0.68) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL10638468 0.94 KMT2A (0.65) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL20190032 0.86 APP (0.71) KMT2AMEN1POLBKDM4EMAPK1
Resazurin SCHEMBL29375844 0.84 KDM4E (1.00) KMT2AMEN1POLBKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116626001-B Method for measuring adsorption rate of sulfate reducing bacteria on coal surface based on fluorescence spectrophotometry 中国矿业大学 2024-04-05 CN claimed
CN-116626001-A Method for measuring adsorption rate of sulfate reducing bacteria on coal surface based on fluorescence spectrophotometry 中国矿业大学 2023-08-22 CN claimed
CN-111307775-A Method for detecting PBMC activity under in-vitro 3D culture condition by applying resazurin reagent 郑州鲲鹏健康科技有限公司 2020-06-19 CN claimed
US-20200080979-A1 METHOD AND DEVICES FOR THE SPECTROPHOTOMETRIC DETERMINATION OF RESIDUAL PHASE TRANSFER CATALYST IN A PET RADIOPHARMACEUTICAL DOSE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2020-03-12 US claimed
US-20130217765-A1 MULTIFUNCTIONAL NANOCONJUGATES AND USES THEREOF WISYS TECHNOLOGY FOUNDATION, INC. 2013-08-22 US claimed
CN-100379877-C Method of monitoring biofouling in membrane separation systems NALCO CORP (US) 2008-04-09 CN claimed
CN-1685060-A Method of monitoring biofouling in membrane separation systems NALCO CORP (US) 2005-10-19 CN claimed
JP-2046291-A None JP disclosed
JP-62019099-A None JP disclosed
JP-6209766-A None JP disclosed
JP-9124076-A None JP disclosed
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY UNIV LELAND STANFORD JUNIOR (US) 2024-07-18 US disclosed
US-12036234-B2 Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues NORTHWESTERN UNIVERSITY (US) 2024-07-16 US disclosed
US-5035998-A Hydrolase substrates BOEHRINGER MANNHEIM GMBH (DE) 1991-07-30 US disclosed
JP-H0246291-A RECOMBINANT DNA CONTAINING GENE OF BETA-GALACTOSE AMANO PHARMACEUT CO LTD 1990-02-15 JP disclosed
US-4900822-A New hydrolase substrates BOEHRINGER MANNHEIM GMBH (DE) 1990-02-13 US disclosed
US-4716222-A CHROMOGENS, SPECTROPHOTOMETRY HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-29 US disclosed
JP-S6219099-A JUDGMENT OF QUALITY OF MALT OR THE LIKE SAPPORO BREWERIES LTD 1987-01-27 JP disclosed
US-4540666-A Methane fermentation MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) 1985-09-10 US disclosed
JP-H00246291-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217765-A1 MULTIFUNCTIONAL NANOCONJUGATES AND USES THEREOF CD47, CLTA, CD63 THRB 3490/4885ESR2 2655/4885CA12 48/4885
US-12036234-B2 Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues COL14A1, MATR3, COL2A1 THRB 2421/4885ESR2 2966/4885CA12 1201/4885
US-20240240226-A1 FLUOROGENIC ASSAY FOR RAPID SCREENING OF BACTERIAL BETA-LACTAMASE ACTIVITY CDA, CMBL, CTSF THRB 3420/4885ESR2 1654/4885CA12 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.